These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18602524)

  • 1. Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapy.
    Trimble MA; Borges-Neto S; Velazquez EJ; Chen J; Shaw LK; Pagnanelli R; Garcia EV; Iskandrian AE
    Am J Cardiol; 2008 Jul; 102(2):211-7. PubMed ID: 18602524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular mechanical dyssynchrony as assessed by phase analysis of ECG-gated SPECT myocardial perfusion imaging.
    Chen J; Garcia EV; Lerakis S; Henneman MM; Bax JJ; Trimble MA; Borges-Neto S; Velazquez EJ; Iskandrian AE
    Echocardiography; 2008 Nov; 25(10):1186-94. PubMed ID: 18986406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?
    Henneman MM; Chen J; Dibbets-Schneider P; Stokkel MP; Bleeker GB; Ypenburg C; van der Wall EE; Schalij MJ; Garcia EV; Bax JJ
    J Nucl Med; 2007 Jul; 48(7):1104-11. PubMed ID: 17574987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear imaging in cardiac resynchronization therapy.
    Henneman MM; van der Wall EE; Ypenburg C; Bleeker GB; van de Veire NR; Marsan NA; Chen J; Garcia EV; Westenberg JJ; Schalij MJ; Bax JJ
    J Nucl Med; 2007 Dec; 48(12):2001-10. PubMed ID: 18056333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
    Van de Veire NR; Marsan NA; Schuijf JD; Bleeker GB; Wijffels MC; van Erven L; Holman ER; De Sutter J; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2008 Apr; 101(7):1023-9. PubMed ID: 18359325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy may improve symptoms of congestive heart failure in patients without electrical or mechanical dyssynchrony.
    Nazeri A; Massumi A; Rasekh A; Saeed M; Frank C; Wilson JM; Lopez JA; Razavi M
    Europace; 2009 Jan; 11(1):86-8. PubMed ID: 19056743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular lead placement in cardiac resynchronization therapy: where and how?
    Khan FZ; Virdee MS; Fynn SP; Dutka DP
    Europace; 2009 May; 11(5):554-61. PubMed ID: 19372115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical dyssynchrony from the perspective of a cardiac electrophysiologist.
    Beshai JF; Khunnawat C; Lin AC
    Curr Opin Cardiol; 2008 Sep; 23(5):447-51. PubMed ID: 18670255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment.
    Bleeker GB; Bax JJ; Steendijk P; Schalij MJ; van der Wall EE
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):213-9. PubMed ID: 16568130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mechanical dyssynchrony by phase analysis of gated single photon emission computed tomography in end-stage renal disease.
    Aljaroudi W; Koneru J; Iqbal F; Aggarwal H; Heo J; Iskandrian AE
    Am J Cardiol; 2010 Oct; 106(7):1042-7. PubMed ID: 20854972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between QRS complex notch and ventricular dyssynchrony in patients with heart failure and prolonged QRS duration.
    Fazelifar AF; Bonakdar HR; Alizadeh K; Azarnik H; Haghjoo M; Abkenar HB; Samiei N; Sadr-Ameli MA
    Cardiol J; 2008; 15(4):351-6. PubMed ID: 18698544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy.
    Jansen AH; Bracke F; van Dantzig JM; Peels KH; Post JC; van den Bosch HC; van Gelder B; Meijer A; Korsten HH; de Vries J; van Hemel NM
    Eur J Echocardiogr; 2008 Jul; 9(4):483-8. PubMed ID: 17826355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy.
    Bleeker GB; Schalij MJ; Van Der Wall EE; Bax JJ
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):899-901. PubMed ID: 16903969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
    Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy.
    Rocchi G; Bertini M; Biffi M; Ziacchi M; Biagini E; Gallelli I; Martignani C; Cervi E; Ferlito M; Rapezzi C; Branzi A; Boriani G
    Eur Heart J; 2009 Jan; 30(1):89-97. PubMed ID: 18987095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
    Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
    Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of dyssynchrony using ECG-gated SPECT myocardial perfusion imaging prior to and following cardiac resynchronization therapy.
    Keida T; Ohira H; Fujita M; Chinen T; Nakamura K; Kato T; Sakakibara N; Ihara Z; Takami M
    Circ J; 2009 Aug; 73(8):1550-3. PubMed ID: 19139591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.